rosiglitazone has been researched along with Hypertension, Pulmonary in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedi, B; Green, DE; Hart, CM; Kang, BY; Murphy, TC; Sadikot, RT; Yuan, Z | 1 |
| Ahsan, F; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR | 1 |
| Choi, CW; Choi, JH; Kim, BI; Kim, EK; Kim, HS; Lee, HJ; Lee, JA; Lee, YJ | 1 |
| Dong, L; Han, D; Li, M; Li, S; Liu, L; Lu, J; Wang, G; Xie, X; Xu, J; Zhang, D; Zhang, Y | 1 |
| Chen, X; Chen, Y; Jia, J; Jiang, Q; Lu, W; Tian, L; Wang, J; Wang, Y; Yang, K; Yun, X; Zhang, B; Zhang, J | 1 |
| Bijli, KM; Carthan, KA; Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, KK; Searles, CD; Sutliff, RL; Yeligar, SM | 1 |
| Archer, D; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, K; Sutliff, RL | 1 |
| Bland, JM; Hart, CM; Kleinhenz, DJ; Mitchell, PO; Nisbet, RE; Sutliff, RL; Walp, ER | 1 |
| Crossno, JT; Garat, CV; Klemm, DJ; Reusch, JE; Sullivan, TM | 1 |
| Kim, EK; Lee, JH; Lee, SD; Lee, YS; Oh, YM | 1 |
| Clapp, LH; Falcetti, E; Hall, SM; Haworth, SG; Morrell, NW; Patel, J; Phillips, PG | 1 |
| Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Page, P; Sutliff, RL; Szyndralewiez, C | 1 |
| Fang, X; Fung, ML; Huang, Y; Liu, Y; Mao, G; Shyy, JY; Tian, XY; Wang, N | 1 |
| Guo, J; Li, G; Lu, WX; Wang, XF; Zhang, YJ | 1 |
| Crossno, JT; Dempsey, EC; Garat, CV; Klemm, DJ; McMurtry, IF; Morris, KG; Reusch, JE; Stenmark, KR | 1 |
| Hansmann, G; Perez, VA; Rabinovitch, M; Schellong, S; Sheikh, AY; Stewart, DJ; Suen, RS; Urashima, T; Wagner, RA; Wang, L | 1 |
| Alastalo, TP; Alvira, CM; Bekker, JM; de Jesus Perez, VA; Guignabert, C; Hansmann, G; Morrell, NW; Rabinovitch, M; Schellong, S; Urashima, T; Wang, L | 1 |
17 other study(ies) available for rosiglitazone and Hypertension, Pulmonary
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
Topics: Animals; Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Lung; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; RNA-Binding Proteins; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
Topics: Administration, Inhalation; Animals; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sildenafil Citrate; Vascular Remodeling | 2019 |
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia.
Topics: Animals; Bronchopulmonary Dysplasia; Female; Hypertension, Pulmonary; Immunohistochemistry; Lung; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2014 |
Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
Topics: Animals; Blotting, Western; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Gene Expression Regulation; Heme Oxygenase-1; Hypertension, Pulmonary; Hypoglycemic Agents; Immunoblotting; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2014 |
Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.
Topics: Animals; Calcium Signaling; Cell Hypoxia; Cell Movement; Cell Proliferation; Cells, Cultured; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; PPAR gamma; Promoter Regions, Genetic; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Transcriptional Activation; TRPC Cation Channels | 2015 |
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Topics: 3' Untranslated Regions; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; PPAR gamma; Pulmonary Artery; Pyrroles; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection; Vascular Remodeling | 2016 |
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
Topics: Anemia, Sickle Cell; Animals; Blood Pressure; Endothelial Cells; Endothelin-1; Gene Knockdown Techniques; Hemin; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ligands; Lung; Mice; MicroRNAs; Models, Biological; PPAR gamma; Proto-Oncogene Protein c-ets-1; Pulmonary Artery; Rosiglitazone; Systole; Thiazolidinediones; Up-Regulation | 2017 |
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.
Topics: Animals; Blood Pressure; Cell Proliferation; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypoxia; Ligands; Male; Mice; NADPH Oxidase 4; NADPH Oxidases; Organ Size; PPAR gamma; PTEN Phosphohydrolase; Receptor, Platelet-Derived Growth Factor beta; Rosiglitazone; Signal Transduction; Superoxides; Thiazolidinediones; Vasodilator Agents | 2010 |
Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
Topics: Animals; Becaplermin; Blotting, Western; Casein Kinase II; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cytosol; Hypertension, Pulmonary; Hypoxia; Male; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR alpha; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Rats; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2010 |
Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats.
Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Male; PPAR gamma; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factors | 2010 |
Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Blotting, Western; Cell Proliferation; Down-Regulation; Epoprostenol; HEK293 Cells; Humans; Hypertension, Pulmonary; Iloprost; Immunohistochemistry; Mice; Muscle, Smooth, Vascular; PPAR gamma; Prostaglandins, Synthetic; Receptors, Epoprostenol; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2010 |
The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Gene Expression; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Hypertension, Pulmonary; Lung; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NADPH Oxidase 4; NADPH Oxidases; PPAR gamma; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrazoles; Pyrazolones; Pyridines; Pyridones; RNA Interference; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1; Ventricular Remodeling | 2012 |
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Topics: Animals; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Receptor, Serotonin, 5-HT2B; Rosiglitazone; Serotonin 5-HT2 Receptor Agonists; Thiazolidinediones; Thiophenes; Transcription Factor AP-1; Up-Regulation | 2012 |
[Protective effects of rosiglitazone intervention on monocrotaline-induced pulmonary arterial hypertension in rats and related inflammatory mechanisms].
Topics: Animals; Hypertension, Pulmonary; Inflammation; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2012 |
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.
Topics: Animals; Blood Pressure; Collagen; Elastin; Extracellular Matrix; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; PPAR gamma; Proto-Oncogene Proteins c-kit; Pulmonary Artery; Rats; Rats, Inbred WKY; Rosiglitazone; Thiazolidinediones | 2007 |
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
Topics: Adiponectin; Animals; Apolipoproteins E; Becaplermin; Cell Proliferation; Cells, Cultured; Diet; Disease Models, Animal; Female; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-sis; Risk Factors; Rosiglitazone; Sex Factors; Thiazolidinediones | 2007 |
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.
Topics: Animals; Apolipoproteins E; Becaplermin; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoglycemic Agents; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-sis; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta | 2008 |